AVAVA MIRIA General Use

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorAVAVA, Inc.

About this trial

A general protocol to treat a variety of dermatologic conditions and collect patient feedback.

Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.

Eligibility criteria

Qualifiers

Male or female subjects between 18 to 70 years of age.

Wrinkles

Scars

Acne Scars

Disqualifiers

Skin pathology or condition that could interfere with evaluation of the study procedure, e.g.,

Systemic treatment prescribed within previous 6 months (e.g., oral medication such as isotretinoin)

Surgical treatment in the target areas within previous 6 months (e.g., laser surgery)

Active vitiligo, psoriasis, or eczema in the treatment area

Trial design

Treatments tested in this trial

  • AVAVA

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators